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In Brief
Autophagy initiation is regulated by
ULK1, a serine/threonine kinase. Pyo
et al. demonstrate that ULK1 is O-
GlcNAcylated on threonine 754 by OGT
upon glucose starvation. O-
GlcNAcylation of ULK1 is crucial for
activating VPS34 via ATG14L. Our
findings provide new insights into the
crosstalk between dephosphorylation
and O-GlcNAcylation during the
autophagy process.
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Unc-51-like-kinase 1 (ULK1) is a target of both the
mechanistic target of rapamycin (mTOR) and AMP-
activated protein kinase (AMPK), whose role is to
facilitate the initiation of autophagy in response to
starvation. Upon glucose starvation, dissociation of
mTOR from ULK1 and phosphorylation by AMPK
leads to the activation of ULK1 activity. Here, we
provide evidence that ULK1 is the attachment of
O-linked N-acetylglucosamine (O-GlcNAcylated) on
the threonine 754 site by O-linked N-acetylglucos-
amine transferase (OGT) upon glucose starvation.
ULK1 O-GlcNAcylation occurs after dephosphory-
lation of adjacentmTOR-dependent phosphorylation
on the serine 757 site by protein phosphatase 1 (PP1)
and phosphorylation by AMPK. ULK1 O-GlcNAcyla-
tion is crucial for binding and phosphorylation
of ATG14L, allowing the activation of lipid kinase
VPS34 and leading to the production of phosphatidy-
linositol-(3)-phosphate (PI(3)P), which is required for
phagophore formation and initiation of autophagy.
Our findings provide insights into the crosstalk
between dephosphorylation and O-GlcNAcylation
during autophagy and specify a molecular frame-
work for potential therapeutic intervention in auto-
phagy-related diseases.INTRODUCTION
Autophagy refers to the catabolic process through which cells
eliminate cytoplasmic components by delivering them to lyso-
somes (Mizushima et al., 2010). It is characterized by several
steps, involving nucleation and elongation of the isolated mem-
brane, followed by the double-membrane structure, forming a
vesicle to fuse with a lysosome to yield autolysosome. Cargo is
then degraded and recycled in the autolysosome (Abada and
Elazar, 2014). Such metabolites generated by autophagy are2878 Cell Reports 25, 2878–2890, December 4, 2018 ª 2018 The Au
This is an open access article under the CC BY-NC-ND license (http://reused as sources of energy or building blocks for the synthesis
of new macromolecules.
Autophagy initiation is regulated by Unc-51-like kinase
1 (ULK1), which functions as a serine/threonine kinase and is
mainly present in the cytosolic organelles such as endoplasmic
reticulum (ER), lysosomes, mitochondria, and cytosol. The for-
mation of the ULK1, ATG13, and FIP200 complex is not altered
by nutrient conditions nor mechanistic target of rapamycin
(mTOR) signaling in mammals (Hosokawa et al., 2009; Shang
and Wang, 2011). When activated, ULK1 phosphorylates
ATG13 and FIP200, triggering complex activity in the initial steps
of autophagosome biogenesis (Jung et al., 2009).
There are two major upstream regulators of ULK1: the mTOR
complex 1 (mTORC1) and AMP-activated protein kinase
(AMPK). mTORC1 is a protein complex consisting of mTOR
serine/threonine kinase, Raptor, MLST8, PRAS40, and DEP
domain-containing mTOR interacting protein (DEPTOR). It func-
tions as an ATP and amino acid sensor to balance nutrient avail-
ability and cell growth, and the activation of mTORC1 inhibits
autophagy (Mizushima et al., 2010). ULK1 is phosphorylated
on serine 637 and 757 sites by mTOR in nutrient-rich conditions,
inhibiting ULK1 activation by disrupting its binding to AMPK
(Hosokawa et al., 2009; Mizushima et al., 2010). Conversely,
AMPK regulates cellular metabolism to maintain energy homeo-
stasis and promotes autophagy. Several studies have confirmed
the positive regulation of ULK1 activity through AMPK-depen-
dent phosphorylation. The S555 site of ULK1 is one of the major
AMPK-dependent phosphorylation sites. In addition, several
other sites of AMPK-dependent phosphorylation have been
identified, such as S317, S467, T574, S637, and S777 (Egan
et al., 2011; Kim et al., 2011). Among them, S317 and S777 are
known to regulate the kinase activity of ULK1. S467, S555, and
T574 are sites responsible for regulating mitochondrial homeo-
stasis during starvation. S637 is the site where both mTORC1
and AMPK phosphorylate.
The attachment of O-linked N-acetylglucosamine (O-GlcNA-
cylation) is the covalent attachment of N-acetylglucosamine
(GlcNAc) sugars to serine or threonine residues of protein sub-
strates. It is catalyzed by a single enzyme, O-linked N-acetylglu-
cosamine transferase (OGT), which transfers N-acetylglucos-
amine from uridine diphosphate (UDP)-GlcNAc to proteinthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. ULK1 Is O-GlcNAcylated by OGT on the Threonine 754 Site
(A) Co-immunoprecipitation of endogenous ULK1 with OGT in H1299 cells.
(B) Co-immunoprecipitation assay between ULK1 and OGT in WT or ULK1/ HEK293 cells.
(C) Detection of ULK1 O-linked N-acetylglucosamine (O-GlcNAcylation) after in vitro O-GlcNAcylation assay.
(D) H1299 cells were treated with OGA inhibitor, Thiamet G (1 mM), followed by either pull down of O-GlcNAcylated proteins using succinyl wheat germ agglutinin
(SWGA) or immunoprecipitation to detect ULK1 O-GlcNAcylation.
(E) ULK1 WT or deletion mutants, including D279–833, 1–600, and 279–833 aa, were tested for O-GlcNAcylation.
(legend continued on next page)
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substrates. A single enzyme, known as O-GlcNAcase (OGA),
rapidly removes the O-GlcNAcylation from protein substrates
(Slawson and Hart, 2011; Vocadlo, 2012). These two opposing
enzymes dynamically alter the posttranslational modification
state and protein functions in response to various signals and
cellular processes. OGT is enriched in the nucleus, yet it is also
present in the cytosol (Zeidan and Hart, 2010). Insights into the
function of OGT has more extensively come from studies
focusing on O-GlcNAcylation of nuclear proteins such as histone
H2B, histone-modifying enzymes such as EZH2 and HDAC1,
and transcription factors such as Oct4 and Sox2 (Chen et al.,
2013; Chu et al., 2014; Jang et al., 2012; Zhu et al., 2016).
There has been speculation that OGT may work closely with
phosphatases since O-GlcNAcylation and phosphorylation
share the same target residues serine and threonine, and there-
fore are most likely antagonistic to each other, such as in the
cases of the CRTC2, p53, and CK2 proteins (Cheng and Hart,
2001; Chou et al., 1995; Dentin et al., 2008; Du et al., 2001;
Tarrant et al., 2012; Yang et al., 2006). In support of this idea,
OGT and phosphatases such as protein phosphatase 1b
(PP1b) and PP1g have been co-purified (Wells et al., 2004),
although common targets of OGT and such phosphatases
have not been identified thus far. It is notable that while kinases
regulating ULK1 phosphorylation are well documented, the only
phosphatase that has been reported is PP2A, which dephos-
phorylates ULK1 on the serine 637 site (Wong et al., 2015).
ULK1 regulates localization of a class III phosphatidylinositol
3 (PI3) kinase called VPS34, which phosphorylates the 30 posi-
tion of the phosphatidylinositol to produce PI(3) phosphate
(PI(3)P), a key molecular marker for intracellular trafficking and
autophagosome formation (Backer, 2008; Hara et al., 2008; Ita-
kura andMizushima, 2010). VPS34 is the only PI3 kinase in yeast
and is essential for protein sorting to the vacuole via the endoly-
sosomal pathway by producing PI(3)P (Backer, 2016; Schu et al.,
1993). PI(3)P is localized to the endosomal compartment and is
required for recruitment of downstream factors that contain
PI(3)P-binding domains (Misra et al., 2001). VPS34 exists in
different complexes and is involved in a variety of cellular func-
tions such asmultivesicular body pathway, retrograde trafficking
from endosomes to the Golgi, phagosomematuration, and auto-
phagy (Backer, 2008). It forms a stable complex with VPS15.
VPS15 can also associate with Beclin1, which serves as a bind-
ing partner for several proteins that either promote (i.e., ATG14L,
UVRAG, Bif1, and AMBRA-1) or inhibit (i.e., Bcl2, BclxL, and
Rubicon) the autophagic function of VPS34 (Itakura et al.,
2008; Liang et al., 2006; Matsunaga et al., 2009; Pattingre
et al., 2009; Sun et al., 2008; Takahashi et al., 2007; Zalckvar
et al., 2009; Zhong et al., 2009). In particular, ATG14L functions
as a positive regulator of autophagosome formation because
it determines the localization of VPS34, and the association
with VPS34 complex is a prerequisite for the activation of
VPS34 lipid kinase activity via AMPK (Kim et al., 2013; Matsu-(F) ULK1 WT or point mutants T635V, T754Y, and T635V/T754Y were pulled dow
(G) ETD mass spectrometry analysis revealed that the site of O-GlcNAcylation w
(H) The site of ULK1 O-GlcNAcylation is conserved throughout species.
(I) Threonine 754 mutated to tyrosine (Y), asparagine (N), or alanine (A), respectiv
validate the site of O-GlcNAcylation by co-immunoprecipitation.
2880 Cell Reports 25, 2878–2890, December 4, 2018naga et al., 2009). However, little has been investigated
regarding the mechanism of how ATG14L associates with the
VPS34-Beclin1 complex.
Here, we provide evidence that ULK1 is O-GlcNAcylated by
OGT on the T754 site during glucose starvation. ULK1 O-GlcNA-
cylation is crucial for the proper activation of VPS34 via ATG14L,
the step that is essential for PI(3)P production, phagophore for-
mation, and subsequent autophagy initiation.
RESULTS
ULK1 Is O-GlcNAcylated by OGT on the Threonine 754
Site
Since ULK1 functions as an important gatekeeper for the initia-
tion of autophagy, we decided to look for possible upstream reg-
ulators of ULK1.We found that ULK1 andOGT interact with each
other. A co-immunoprecipitation assay using antibody against
ULK1 revealed that ULK1 bound to OGT at the endogenous
expression level (Figure 1A). We generated ULK1/ HEK293
cells using CRISPR/Cas9 and confirmed the specific interaction
betweenULK1 andOGT (Figure 1B). This led us to speculate that
ULK1 may be a target of OGT. To verify whether O-GlcNAcyla-
tion occurs on ULK1, an in vitro OGT assay was performed.
The introduction of OGT induced the O-GlcNAcylation of
ULK1 (Figure 1C). Also, treatment of cells with the OGA inhibitor
Thiamet G increased ULK1 O-GlcNAcylation, while the total
protein level of ULK1 did not change (Figure 1D).
Next, we set out to identify the site of O-GlcNAcylation on
ULK1. Several deletion mutants of ULK1 were tested for
O-GlcNAcylation. Full-length D279–833, which has the 279–
833 amino acid (aa) region deleted, 1–600 aa, and 279–833 aa
were expressed in HEK293 cells and immunoprecipitated for
O-GlcNAc band detection. ULK1 was O-GlcNAcylated only in
the 601–833 aa region (Figure 1E). Although a recent study sug-
gests that ULK1 is O-GlcNAcylated at two different sites, threo-
nine 635 and threonine 754 (Ruan et al., 2017), in our context,
threonine 754 was the major site of O-GlcNAcylation (Figure 1F).
We went further to confirm the exact site of O-GlcNAcylation
by electron transfer dissociation (ETD) mass spectrometric anal-
ysis and verified that ULK1 is O-GlcNAcylated on the threonine
754 site, which is well conserved across species (Figures 1G,
1H, and S1).
In addition, three different T754 mutants (T754A, T754N, and
T754Y) of ULK1 were tested. We mutated threonine to alanine
(A). Being close to the mTOR-mediated serine 757 (S757) phos-
phorylation site, we also decided to mutate T754 to asparagine
(N) or tyrosine (Y), since these aas are conserved mTOR target
motif sequences in the corresponding position (Hsu et al.,
2011). We reasoned that mTOR-mediated phosphorylation on
the S757 site should not be neglected because previous studies
have shown that mTOR phosphorylates ULK1 in nutrient-rich
conditions, while upon starvation, ULK1 phosphorylation byn with anti-FLAG antibody, and their O-GlcNAcylation band was detected.
ithin ULK1 is threonine 754.
ely. A residue other than T754, such as S757, was also mutated to alanine to
Figure 2. ULK1 O-GlcNAcylation Increases during Glucose Starvation
(A and B) Glucose starvation for the indicated times in H1299, HEK293, and SW620 cells. Samples were co-immunoprecipitated against anti-ULK1 antibody, and
either endogenous OGT (A) or O-GlcNAcylation (B) levels were detected. The OGT/ULK1 or LC3-II/b-actin ratio is indicated.
(C) H1299 cells were glucose starved and resupplied for 4 hr before harvest.
(D)WT HEK293 cells were compared withULK1/HEK293 cells to confirm ULK1-specific O-GlcNAcylation. SWGA beads were used to detect O-GlcNAcylation
with or without N-acetyl-D-glucosamine (NADG), which mimics the free form of UDP-GlcNAc.
(legend continued on next page)
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mTOR is diminished, which releases ULK1 from the inactive
state (Kim et al., 2011). Therefore, several conserved-motif-
based T754 mutants were made to ensure that mTOR-depen-
dent phosphorylation occurs appropriately. In support of the
ETD mass spectrometry data, co-immunoprecipitation and
immunoblot analyses confirmed ULK1 O-GlcNAcylation on
T754, since only WT but not T754Y, T754N, or T754A was
O-GlcNAcylated (Figure 1I). We observed that the T754A mutant
diminished S757 phosphorylation dynamics, which would affect
the study on the interplay between O-GlcNAcylation by OGT
and phosphorylation by mTOR (Figure S2). Therefore, we used
the T754Nmutant to explore the function of ULK1 O-GlcNAcyla-
tion thereafter.
Increased ULK1 O-GlcNAcylation Is Positively
Correlated to Autophagosome Formation during
Glucose Starvation
ULK1 activity largely depends on the availability of nutrients, and
nutrient starvation conditions such as glucose starvation in-
crease ULK1 activity (Kim et al., 2011; Shang and Wang,
2011). Therefore, we examined whether ULK1 and OGT interac-
tion is affected by glucose starvation. Several different cell
lines, including H1299, HEK293, and SW620, similarly showed
increased binding between ULK1 andOGT upon glucose starva-
tion (Figure 2A). In parallel, ULK1 O-GlcNAcylation levels
increased during glucose starvation, which was in conjunc-
tion with increased LC3-phosphatidylethanolamine conjugate
(LC3 II) conversion, a marker for autophagosomes and autolyso-
somes (Figure 2B), indicating that ULK1 O-GlcNAcylation has
a positive correlation with autophagy occurrence in these cell
lines. Furthermore, we reasoned that if glucose levels and
ULK1 O-GlcNAcylation levels have inverse correlations,
reversing glucose levels in the media would reverse ULK1
O-GlcNAcylation levels. Glucose starvation followed by glucose
repletion resulted in the reversal of the modification, with a
marked decrease in ULK1 O-GlcNAcylation levels after the
restoration of glucose in the media (Figure 2C). We also
confirmed that the ULK1 O-GlcNAcylation band disappeared
when free N-acetyl-D-glucosamine ([NADG] mimics free UDP-
GlcNAc) was added to the succinyl wheat germ agglutinin
(SWGA) bead, but no such band appeared in the ULK1/
HEK293 cells, indicating that the O-GlcNAcylation band is spe-
cific to ULK1 (Figure 2D).
We further examined whether knock down of OGT would
result in the reduction of ULK1 O-GlcNAcylation levels and sub-
sequently lead to the inhibition of autophagy. First, we confirmed
dramatically decreased ULK1 O-GlcNAcylation levels over the(E) Knock down of nonspecific (siNS) or OGT (siOGT), followed by glucose starv
(F) Representative image of immunocytochemistry after knock down of nonspec
(green) for the quantification of LC3 puncta in H1299 cells. Nuclei visualized by
periments performed using the same conditions. Scale bar, 10 mm. The p value w
(G) Immunoprecipitation assay was performed in parallel with the immunocyto
reduction in ULK1 O-GlcNAcylation.
(H) Representative image of immunocytochemistry after knockdown of endogeno
resistant ULK1 in H1299 cells. All of the cells were glucose starved to induce auto
was done before fixation. Similar results were obtained in three independent exp
was calculated by one-way ANOVA (***p < 0.0001). Data are expressed as mea
ULK1 WT or T754N mutants in H1299 cells in parallel with the immunocytochem
2882 Cell Reports 25, 2878–2890, December 4, 2018course of starvation when OGT was knocked down by small
interfering RNA (siRNA) (Figure 2E). Second, we used GFP-LC3
puncta as readout for autophagy occurrence and found that
the number of GFP-LC3 puncta decreased when the OGT level
was diminished, further indicating that OGT knockdown inhibits
autophagosome formation (Figures 2F and 2G). To more pre-
cisely assess whether ULK1 O-GlcNAcylation modulates auto-
phagosome formation, ULK1 was knocked down using siRNA,
and then the siRNA-resistant ULK1 wild-type (WT) or T754N
mutant was reconstituted. The mCherry-GFP-LC3 reporter was
used to assess the overall number of LC3 puncta formations
as well as autophagic flux. The GFP is attenuated in the
acidic lysosomal environment, whereas the mCherry is not.
This reporter allows the distinction between autophagosomes
(GFP+/mCherry+ yellow puncta) and autolysosomes (GFP/
mCherry+ red puncta) to be made. The total numbers of both au-
tophagosomes and autolysosomes were significantly reduced
when the T754N mutant was reconstituted in contrast to WT
reconstitution (Figure 2H), indicating that ULK1 O-GlcNAcylation
positively regulates autophagosome formation. Bafilomycin A1,
which inhibits the fusion between autophagosomes and lyso-
somes, was used to assess autophagic flux. Treatment with
bafilomycin A1 resulted in significantly increased autophago-
somes for both WT and T754N mutants. This increased number
of nascent autophagosomes unable to fuse with lysosomes indi-
cates that the major function of ULK1 O-GlcNAcylation is in the
early regulation of autophagy progression (Figures 2H).
Dephosphorylation andO-GlcNAcylation on ULK1Occur
Sequentially
A previous study had quantified phosphorylation dynamics on
711 phosphopeptides through high-throughput mass spectro-
metric analyses (Wang et al., 2008). Elevated O-GlcNAcylation
resulted in reduced phosphorylation on 280 sites and caused
increased phosphorylation on 148 sites. The crosstalk between
these two abundant modifications may have arisen by both ste-
ric competition for occupancy at the same or adjacent sites and
each modification regulating the other’s enzymatic machinery.
Therefore, we decided to examine whether this crosstalk be-
tween O-GlcNAcylation and phosphorylation applies to ULK1,
since it has been reported that ULK1 is phosphorylated by
mTOR on S757 in nutrient-rich conditions (Hwang et al., 2017;
Kim et al., 2011). S757 is only three aas away from the O-GlcNA-
cylation site, and this phosphorylation is known to be signifi-
cantly diminished during nutrient starvation (Kim et al., 2011).
We observed dephosphorylation of ULK1 on S757 simulta-
neously occurring with O-GlcNAcylation on T754 (Figure 3A),ation for the indicated hours.
ific (siNS) or endogenous OGT (siOGT) (red) and overexpression of GFP-LC3
DAPI staining (blue). Similar results were obtained in three independent ex-
as calculated by t test (***p < 0.0001). Data are expressed as means ± SEMs.
chemistry samples to confirm efficient knock down of OGT and subsequent
us ULK1 (siULK1) and reconstitution with WT (WTR) or T754N (T754NR) siRNA-
phagy. Treatment of cells with either vehicle or 40 nM of bafilomycin A1 for 2 hr
eriments performed using the same conditions. Scale bar, 10 mm. The p value
ns ± SEMs. Immunoblot showing knockdown and reconstitution efficiency of
istry experiment.
(legend on next page)
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indicating that these two different modifications may be able
to crosstalk with each other. We also noticed that binding be-
tween ULK1 and mTOR decreased during glucose starvation
(Figure 3A).
Based on the preceding evidence, we set out to test whether
there is a correlation betweenO-GlcNAcylation and phosphoryla-
tion on ULK1. ULK1 phosphorylation bymTOR is known to nega-
tively regulate ULK1 activity when sufficient nutrients are avail-
able. Therefore, we treated cells with Torin 1 to inhibit mTOR
activity and found that ULK1 phosphorylation by mTOR on
S757 decreased as O-GlcNAcylation on T754 increased (Fig-
ure 3B). Next, we reasoned that overexpression of the constitu-
tively active formofmTORwould sufficiently reverse O-GlcNAcy-
lation during glucose starvation for this negative correlation to be
valid. The constitutively active mutant of mTOR (mTOR CA) has
its four sites mutated (I2017T, V2198A, L2216H, and L2260P)
(Das et al., 2012). Using mTOR CA, we verified that O-GlcNAcy-
lation of ULK1was reversed by the overexpression of thismutant.
ULK1 O-GlcNAcylation was dose dependently decreased, while
adjacent phosphorylation dose dependently increased by
mTOR CA overexpression (Figure 3C), indicating the alternative
and reversible aspects of ULK1 T754 O-GlcNAcylation and
S757 phosphorylation. In addition, WT and mutant forms of
ULK1 were tested for O-GlcNAcylation and phosphorylation after
glucose starvation. As expected, both the T754N mutant and the
S757D (phospho-S757 mimic) mutant failed to obtain O-GlcNA-
cylation, while both WT and S757A were capable of being
O-GlcNAcylated (Figure 3D). These results provide evidence for
consecutive dephosphorylation and O-GlcNAcylation during
glucose starvation. In other words, O-GlcNAcylation occurrence
after ULK1 phosphorylation on S757 is significantly diminished.
Next, we predicted that there would be an active phosphatase
responsible for the dephosphorylation of ULK1.We found PP1 to
be the active phosphatase, whose interaction with ULK1 was
significantly stronger than other phosphatases such as PP2A
and PP5 during glucose starvation (Figure 3E). PP5 knock
down resulted in increased LC3 II levels in contrast to PP1, sup-
porting the idea that PP1, but not PP5, would be a strong
candidate phosphatase (Figure S3). Although its protein level re-
mained stable, PP1 showed increased binding to ULK1 duringFigure 3. Dephosphorylation and O-GlcNAcylation on ULK1 Occurs Se
(A) Detection of ULK1 T754 O-GlcNAcylation and S757 phosphorylation after the
(B) Detection of ULK1 O-GlcNAcylation and S757 phosphorylation after treatmen
(C) Overexpression of mTOR constitutively active mutant (mTOR CA), followed b
induce ULK1 O-GlcNAcylation before harvest.
(D) Overexpression of hemagglutinin (HA)-tagged ULK1 WT and mutants T754N
noprecipitation using anti-HA antibody, and immunoblot analysis against the ind
(E) Comparison of binding between ULK1 and phosphatases (PP1, PP2A, and P
(F) Co-immunoprecipitation of endogenous ULK1 and PP1 after the indicated ho
(G) Immunoprecipitation assay detecting ULK1 O-GlcNAcylation in H1299 cells wh
the indicated hours.
(H) Tautomycetin (TMC) treatment (10 nM) for the indicated hours, followed by th
(I) Co-immunoprecipitation of ULK1 and OGT after the overexpression of PP1 in
(J) Overexpression of PP1, followed by detection of ULK1 O-GlcNAcylation and
(K) Detection of ULK1 O-GlcNAcylation and S757 phosphorylation when mTOR
(L) Representative image of immunocytochemistry showing GFP-LC3 (green) pun
Nuclei visualized by DAPI staining (blue). Similar results were obtained in three ind
The p value was calculated by t test (***p < 0.0001). Data are expressed as means
PP1 in parallel with the immunocytochemistry experiment.
2884 Cell Reports 25, 2878–2890, December 4, 2018glucose starvation (Figure 3F). As the binding increased, ULK1
phosphorylation on S757 decreased, indicating the possible
involvement of PP1 in mediating the dephosphorylation of
ULK1 on S757. Furthermore, the interaction between ULK1
and PP1 was visualized by immunocytochemistry. Under
nutrient-rich conditions, ULK1 and PP1 did not colocalize in
the cells, whereas during glucose starvation, their colocalization
was significantly increased (Figure S4). Following the observa-
tion that ULK1 and PP1 colocalize, PP1 was knocked down to
test whether PP1 is essential for ULK1 O-GlcNAcylation to
occur. The absence of PP1 led to a dramatic decrease in ULK1
O-GlcNAcylation during glucose starvation (Figure 3G).
We next determinedwhether this dephosphorylation event oc-
curs specifically by PP1 using a PP1-specific inhibitor, tautomy-
cetin (TMC). The treatment of glucose-starved cells with TMC
resulted in significantly reduced ULK1 O-GlcNAcylation (Fig-
ure 3H), indicating that the dephosphorylation event is required
for O-GlcNAcylation to occur during glucose starvation. In
addition, PP1 overexpression increased the binding between
ULK1 and OGT (Figure 3I). As a result, ULK1 O-GlcNAcylation
increased dose dependently via the overexpression of PP1,
while adjacent phosphorylation on S757 was dramatically
decreased (Figure 3J), indicating that the dephosphorylation
event by PP1 precedes binding between ULK1 and OGT and
subsequent ULK1 O-GlcNAcylation. These results provided
further evidence that the withdrawal of mTOR from ULK1 during
glucose starvation is not sufficient for efficient ULK1O-GlcNAcy-
lation and that an active dephosphorylation event by PP1 is
pivotal for proper interaction between ULK1 and OGT and sub-
sequent O-GlcNAcylation. Also, the overexpression of PP1
was sufficient to overcome the suppression of ULK1 O-GlcNA-
cylation by mTOR, as was indicated by reversed O-GlcNAcyla-
tion and phosphorylation states (Figure 3K). Based on these
results, we predicted that knock down of endogenous PP1
would inhibit autophagosome formation in parallel with the
knock down of endogenous OGT, as shown in Figure 2F. As ex-
pected, knock down of PP1 resulted in the dramatically reduced
number of GFP-LC3 puncta during glucose starvation (Fig-
ure 3L). These data not only represent the close relation between
ULK1 and PP1 but also indicate that PP1 colocalizes with ULK1quentially
indicated hours of glucose starvation in H1299 cells.
t of H1299 cells with mTOR inhibitor Torin 1 for the indicated hours.
y detection of ULK1 O-GlcNAcylation. Cells were glucose starved for 6 hr to
, S757A, and S757D in HEK293 cells, followed by glucose starvation, immu-
icated antibodies.
P5) during glucose starvation in HEK293 cells.
urs of glucose starvation in H1299 cells.
en PP1was knocked down using shRNA and underwent glucose starvation for
e detection of ULK1 O-GlcNAcylation in H1299 cells.
HEK293 cells.
S757 phosphorylation in H1299 cells.
CA is expressed in the absence or presence of PP1 in H1299 cells.
cta in H1299 cells with or without endogenous PP1 knockdown using shRNA.
ependent experiments performed using the same conditions. Scale bar, 10 mm.
± SEMs. Immunoblot analysis showing knockdown efficiency of endogenous
Figure 4. ULK1O-GlcNAcylation Is Crucial for
Activating VPS34 via ATG14L during Auto-
phagy Initiation
(A) Co-immunoprecipitation of ULK1 WT or T754N/
T754Q mutants with endogenous ATG14L, Beclin1,
and VPS34 in HEK293 cells after 3 hr of glucose
starvation. Input was divided in half to perform two
separate co-immunoprecipitation assays.
(B) Knock down of endogenous OGT, followed by
3 hr of glucose starvation and co-immunoprecipi-
tation with anti-ULK1 antibody, followed by immu-
noblot analysis with anti-ATG14L, anti-O-GlcNac,
and ULK1 antibodies in H1299 cells.
(C) Co-immunoprecipitation of endogenous ULK1
and ATG14L when OGT WT mutant or enzymatic
dead mutant is overexpressed in HEK293 cells.
(D) Overexpression of mTOR CA mutant in HEK293
cells upon glucose starvation for 3 hr. A co-immu-
noprecipitation assay was performed with anti-
ULK1 antibody, followed by immunoblot analysis
using the indicated antibodies.
(E) Overexpression of PP1, followed by knock down
of OGT in H1299 cells. Immunoprecipitation was
performed using anti-ULK1 antibody, followed by
immunoblotting using the indicated antibodies.
Glucose starvation was provided for 3 hr before
harvest.
(F) ULK1 WT, T754N, T754Q, S757A, and T754N/
S757A mutants were reconstituted in ULK1/
HEK293 cells. Glucose starvation was provided for
3 hr before harvest.to ensure that ULK1 remains dephosphorylated throughout star-
vation, thereby serving as a gatekeeper between O-GlcNAcyla-
tion by OGT and phosphorylation by mTOR.
ULK1 O-GlcNAcylation Is Crucial for Activating VPS34
via ATG14L during Autophagy Initiation
Since the T754 O-GlcNAcylation site is structurally within the reg-
ulatory region of ULK1, thismodificationmay alter its kinase activ-
ity. Therefore, we performed an in vitro kinase assay using ATG13
as a substrate and found that T754N and T754A mutants ex-
hibited little or no change in kinase activity onATG13 (Figure S5A).
To exclude the possibility that the mutation results in structural
defects, we performed immunoprecipitation of WT and mutantCell RepoULK1 with ATG13. There was no significant
defect in the ability to bind ATG13 (Fig-
ure S5B). Next, we decided to explore other
aspects of ULK1 function that would be
affected by O-GlcNAcylation, such as pro-
tein-protein interaction. We explored the
binding affinity with known ULK1 targets
such as ATG14L and VPS34. Being a posi-
tive regulator of autophagosome formation
and an important regulator of VPS34 com-
plex, ATG14L binding to ULK1 T754N and
T754Q was dramatically decreased when
compared to ULK1 WT (Figure 4A). T754Q
mutant was used as one of the conserved
mTOR target motif-based T754 mutants inaddition to T754N. Knock down of OGT significantly decreased
the interaction between ULK1 and ATG14L (Figure 4B). Based
on our observation that ULK1 O-GlcNAcylation is required for
proper binding to ATG14L, we examined whether overexpression
of either WT or the enzymatically deadmutant of OGT would alter
the binding between ULK1 and ATG14L. OGT WT, but not the
mutant, caused increased binding between ULK1 and ATG14L,
confirming the importance of O-GlcNAcylation in facilitating their
interaction (Figure 4C). In addition, since overexpression ofmTOR
CA led to decreased O-GlcNAcylation in Figure 3C, we reasoned
that this would also lead to reduced ULK1-ATG14L binding.
ULK1-ATG14L binding decreased, as opposed to S757 phos-
phorylation, which increased due to mTOR activity (Figure 4D).rts 25, 2878–2890, December 4, 2018 2885
Figure 5. Phosphorylation byAMPKPrecedes
ULK1 O-GlcNAcylation
(A andB) H1299 cells were treatedwithCompoundC
(10 mM) (A) or knocked down by AMPKa shRNA (B)
during glucose starvation for the indicated hours.
Immunoprecipitation was performed with anti-ULK1
antibody, followed by immunoblot analysis using the
indicated antibodies.
(C and D) HA-tagged ULK1 WT, S317A, S467,
S555A, T574A, S637A, and S777A mutants (C) or
HA-tagged ULK1 WT, S317D, S467D, S555D,
T574D, S637D, and S777D mutants (D) were over-
expressed with OGT in HEK293 cells and provided
glucose starvation for 3 hr before harvest. Immuno-
precipitation was performed using anti-HA antibody
followed by immunoblotting using the indicated
antibodies. The O-GlcNAc/HA ratio is indicated.One may argue the legitimacy of O-GlcNAcylation because
the dephosphorylation event may be sufficient to trigger the
interaction between ULK1 and ATG14L. To test this possibility,
we overexpressed PP1 to dephosphorylate ULK1 and then
knocked down OGT so that ULK1 remained dephosphorylated
and deO-GlcNAcylated. The interaction between ULK1 and
ATG14L diminished when OGT was knocked down, indicating
that O-GlcNAcylation has its own function besides crosstalk
with the adjacent phosphorylation (Figure 4E). We continued to
confirm the hypothesis by comparing ULK1 WT with O-GlcNAc
mutants T754N and T754Q, phosphorylation mutant S757A,
and double mutant T754N/S757A. T754N/S757A mutant was
included because this form would represent dephosphorylated
and deO-GlcNAcylated state of ULK1. Only WT and S757A mu-
tants were able to bind ATG14L, indicating that dephosphory-
lated and deO-GlcNAcylated ULK1 showed attenuated binding
to ATG14L (Figure 4F). In summary, O-GlcNAcylation requires
the dephosphorylation event, yet it confers onto ULK1 its own
function, which is the interaction with ATG14L.
Phosphorylation by AMPK Occurs Before ULK1 O-
GlcNAcylation
Based on the previous studies that showed that AMPK and
mTORC1 are antagonistic to each other in the function of ULK1,
we wondered where O-GlcNAcylation would fit. We treated cells
with an AMPK inhibitor, Compound C, during glucose starvation
and observed dramatically decreased O-GlcNAcylation and
AMPK-dependent S555 phosphorylation on ULK1 (Figure 5A).
This result supports the idea that O-GlcNAcylation occurs after
AMPK phosphorylates ULK1 and that this phosphorylation is
required for O-GlcNAcylation to occur. To further verify this hy-
pothesis, we transiently knocked down AMPKa using small
hairpin RNA (shRNA) in glucose-starved cells. In parallel with2886 Cell Reports 25, 2878–2890, December 4, 2018CompoundC treatment,AMPK knockdown
also abolished both ULK1 O-GlcNAcylation
and AMPK-dependent S555 phosphoryla-
tion (Figure 5B).
However, it is possible that since AMPK
has been inhibited or knocked down, the
entire autophagic process may have beenshut down, and OGT may have been affected by it. To exclude
such a possibility, we mutated AMPK-dependent phosphoryla-
tion sites of ULK1, which are S317, S467, S555, T574, S637,
and S777, to alanine (SA) to determine whether this mutation re-
sults in the reduction of O-GlcNAcylation. Two SA mutants
showed significantly diminished O-GlcNAcylation, indicating
that AMPK-dependent phosphorylation on ULK1 S317 and
S555 occurs before O-GlcNAcylation on T754 (Figure 5C).
Conversely, the six sites were mutated to aspartic acid (SD) to
mimic constitutive phosphorylation, and the SD mutation of
S317 and S555 showed increased O-GlcNAcylation bands in
contrast to the SA mutation of them (Figure 5D). This also indi-
cates that phosphorylation of ULK1 by AMPK occurs before
ULK1 O-GlcNAcylation and that it possibly has positive effects
on ULK1 O-GlcNAcylation. These results demonstrate that there
is a sequence of modification steps on ULK1 during glucose
starvation. Dephosphorylation by PP1 and phosphorylation by
AMPK are followed by ULK1 O-GlcNAcylation by OGT, and
these series of events lead to the interaction of ULK1 and
ATG14L.
Interplay between Dephosphorylation and
O-GlcNAcylation of ULK1 Governs the Autophagy
Initiation Process
Based on the evidence that PP1 upregulates ULK1 O-GlcNAcy-
lation and that O-GlcNAcylation is required for the ULK1-
ATG14L interaction, we tested whether the interaction between
ATG14L and ULK1 is affected by the dephosphorylation of
ULK1 on S757 by PP1. The overexpression of PP1 increased
the binding between ULK1 and ATG14L dose dependently dur-
ing glucose starvation (Figure 6A). Since ULK1 is a serine/
threonine kinase and components of the VPS34 complex
such as VPS34 and Beclin1 are phosphorylated by ULK1, we
Figure 6. Interplay between Dephosphorylation and O-GlcNAcylation of ULK1 Governs the Autophagy Initiation Process
(A) Overexpression of PP1 in H1299 cells upon glucose starvation for 3 hr. Co-immunoprecipitation was performed using anti-ULK1 antibody, followed by
immunoblot analysis with the indicated antibodies.
(B) In vitro kinase assay. FLAG-ULK1 overexpressing cells were glucose starved for 3 hr and harvested for pull-down assay with anti-FLAG M2 beads.
The isolated protein was eluted with FLAG peptide for the in vitro kinase assay. Escherichia coli strain M13pRep was used for amplifying and purifying
pQE-His-ATG14L protein by nickel-nitrilotriacetic acid (Ni-NTA) pull-down. 32P was used for detecting phosphorylation on ATG14L.
(legend continued on next page)
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hypothesized that the interaction between ULK1 and ATG14L
would also induce phosphorylation of the VPS34 complex
component ATG14L. This possibility was in line with the previous
report that ATG14L phosphorylation mimics nutrient deprivation
by stimulating the kinase activity of the VPS34 complex and fa-
cilitates the formation of phagophores and autophagosomes
(Park et al., 2016). To visualize the phosphorylation of ATG14L
by ULK1, an in vitro kinase assay was performed. The phosphor-
ylated form of ATG14Lwas detected, and ULK1 phosphorylation
was also detected since it has auto-kinase activity by autoradi-
ography (Figure 6B). Therefore, using this method, we verified
that ULK1 can induce the phosphorylation of ATG14L.
It has been shown that in the presence of ATG14L, the VPS34
complex is activated by AMPK, whereas in the absence of
ATG14L, the VPS34 complex is inhibited by AMPK (Kim et al.,
2013). Based on this information, we hypothesized that the fail-
ure of ULK1-ATG14L binding would result in the failure of
VPS34 lipid kinase activation. An in vitro VPS34 lipid kinase
assay confirmed that the reconstitution ofULK1/HEK293 cells
with the ULK1 WT mutant but not the T754N mutant induced
VPS34 lipid kinase activity (Figure 6C). Another in vitro VPS34
lipid kinase assay was performed by overexpressing PP1 in
HEK293 cells. VPS34 activity was dose dependently induced,
as shown by the increased level of 32P-PI(3)P (Figure 6D).
Given that VPS34 can be involved in non-autophagy pro-
cesses, we set out to further verify whether the ULK1 O-GlcNAc
mutant disrupts an autophagy-specific function of VPS34. Mem-
bers of the human tryptophan-aspartic acid (WD)-repeat protein
interacting with phosphoinositides (WIPI) family play an impor-
tant role in recognizing PI(3)P at the phagophore, and they func-
tion as autophagy-specific PI(3)P-binding effectors (Proikas-
Cezanne et al., 2015). Since WIPI localization is dependent on
VPS34 activity and PI(3)P, WIPI puncta formation was compared
betweenULK1WT- and T754N-reconstituted cells.When under-
going glucose starvation, ULK1 T754N-reconstituted cells ex-
hibited significantly less WIPI puncta than did ULK1 WT-recon-
stituted cells (Figure S6). This result indicates that VPS34
activity, which is indicated by WIPI puncta formation, depends
on ULK1 O-GlcNAcylation. These data highlight that ULK1
O-GlcNAcylation is important for the induction of VPS34 lipid
kinase activity by ATG14L, which is critical for PI(3)P conversion
and phagophore formation.
DISCUSSION
Our study demonstrates that the initiation of autophagy during
glucose starvation is critically regulated by a series of modifica-
tion steps in ULK1, including dephosphorylation by PP1 and
phosphorylation by AMPK, leading to O-GlcNAcylation by
OGT. Moreover, we identify the site of ULK1 O-GlcNAcylation
triggered by the starvation signal and exemplify how ULK1(C and D) Lysates containing FLAG-VPS34 were subjected to pull-down assay w
followed by in vitro lipid kinase assay. 32P-PI(3)P production by VPS34 in response
was measured using thin-layer chromatography (TLC), followed by autoradiogra
statistics. The p value was calculated by t test (*p < 0.01) or one-way ANOVA (**
(E) Schematic model of both dephosphorylation by PP1 and phosphorylation b
starvation, and the consequential regulation of VPS34 activity via ATG14L and p
2888 Cell Reports 25, 2878–2890, December 4, 2018O-GlcNAcylation is crucial for autophagosome formation by
inducing the lipid kinase activity of the VPS34 via ATG14L
(Figure 6E).
Previous studies have reported that OGT is recruited to sites
of PI(3)P formation during growth factor signaling, suggesting
that many signaling cascades triggered by phosphoinositide
3-kinase (PI3K) are likely to be influenced by O-GlcNAcylation
(Yang et al., 2008). By analogy from its recruitment to PI(3)P in
the plasma membrane, OGT has been predicted to be directly
recruited to the forming autophagosome (Hanover et al., 2010).
We identified a specific target of OGT at the pre-autophagoso-
mal structure, ULK1, whose localization to the phagophore re-
cruits ATG14L to induce VPS34, a type III PI3K, and allows the
formation of PI(3)P. Generation of PI(3)P at the phagophore by
VPS34 is a critical event during pre-autophagosomal structure
formation. Two independent studies indicate that ATG14L posi-
tively regulates autophagy by promoting double-membrane for-
mation during autophagy and that ATG14L deficiency causes
defects in autophagosome formation (Matsunaga et al., 2009;
Zhong et al., 2009). Moreover, the activity of ATG14L-containing
VPS34 complex is strongly dependent on ULK1, yet a detailed
regulatory mechanism has not been fully investigated. In the
present study, we provide evidence that ULK1 O-GlcNAcylation
exerts its function by upregulating VPS34 lipid kinase activity via
increased binding between ULK1 and ATG14L.
Furthermore, we addressed how a phosphatase can mediate
O-GlcNAcylation by demonstrating that PP1 dephosphorylates
ULK1 on S757, which is in close proximity to the O-GlcNAcyla-
tion site T754. This may serve as a ‘‘priming event’’ for O-GlcNA-
cylation to occur during glucose starvation and may serve as
an intermediary step between phosphorylation by mTOR and
O-GlcNAcylation by OGT. Likewise, we speculate that there
may be other common targets of PP1 and OGT during glucose
starvation, since it has been reported that during glucose starva-
tion, global O-GlcNAcylation levels rise in H1299 cells (Yi et al.,
2012). Our findings strongly demonstrate that O-GlcNAcylation
of ULK1 on the T754 site occurs to ensure the activation of
VPS34 via increased binding to ATG14L for phagophore forma-
tion. Moreover, we found previously predicted yet never identi-
fied crosstalk between O-GlcNAcylation and dephosphorylation
mediated by PP1 governing ULK1 function during autophagy
initiation.
Phosphorylation of ULK1 on S317 and S555 by AMPK pre-
cedes ULK1 O-GlcNAcylation during glucose starvation. The
phosphorylation status of other sites such as S467, T574, and
S777 appears to have a minimal effect on ULK1 O-GlcNAcyla-
tion, while phosphorylation on S637 does not exert much
influence on the status of ULK1 O-GlcNAcylation. During
glucose starvation, mTOR is inhibited while AMPK is activated;
therefore, during the early stages of autophagy, the net phos-
phorylation on the S637 site remains ambiguous (Shang andith anti-FLAG M2 beads. The isolated protein was eluted with FLAG peptide,
to ULK1WTmutant or TNmutant overexpression (C) or PP1 overexpression (D)
phy. Three independent experiments were performed and were analyzed for
p < 0.001). Data are expressed as means ± SEMs.
y AMPK events leading to O-GlcNAcylation by OGT on ULK1 during glucose
hagophore formation.
Wang, 2011). Moreover, the S757 site is phosphorylated solely
by mTOR, but knock down of AMPK subunits or perturbations
of AMPK activity by inhibitors may affect phosphorylation on
S757 because AMPK inhibits mTOR during starvation. Further
studies using these criteria are needed to validate the exact
underlying mechanism.
Our study indicates that a series of posttranslational modifica-
tions of ULK1 during glucose starvation serves as a gatekeeper
between pro-autophagic and anti-autophagic response, which
is required for the decision-making process during autophagy.
We predict that since autophagy is an energy-consuming pro-
cess involving both short-term and long-term measures for cell
survival, the cell may use a series of steps as checkpoints to
determine whether the rest of the reactions should follow. Our
data highlight the regulation of autophagy by crosstalk between
dephosphorylation and O-GlcNAcylation during the initial stages
of autophagy, offering therapeutic targets for autophagy-related
diseases.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
HEK293 cells were cultured in DMEM supplemented with 5% fetal bovine serum and penicillin (40 U/ml)/streptomycin (40 mg/ml)
at 37C under 5%CO2. H1299 and SW620 cells were cultured in RPMI1640 supplemented with 5% fetal bovine serum and penicillin
(40 U/ml)/streptomycin (40 mg/ml) at 37C under 5% CO2. Cells were transfected using Lipofectamine 3000. For cells that were
treated with glucose starvation, glucose free DMEM or RPMI1640 supplemented with 5% dialyzed fetal bovine serum was used.
METHOD DETAILS
Cell culture
HEK293, H1299, and SW620 cell lines were cultured in DMEM (Welgene, South Korea, LM001-05) or RPMI1640 (Welgene, South Ko-
rea, LM011-01) supplementedwith 10% (v/v) fetal bovine serum (GIBCO, 26140-079), 100 U/ml penicillin and 100 mg/ml streptomycin
(Welgene, South Korea, LS-20301). All cell lines used were regularly tested for mycoplasma contamination. Lipofectamine 3000 (Life
Technologies, 100022052) and Gene In (Global Stem, catalog# 73802, 73012) transfection reagents were used and transfection was
performed according to themanufacturers’ protocol. Cells were harvested 24 to 36 h post-transfection. Experiments were performed
under normal growth conditions, unless otherwise stated. For starvation, cells were washed twice in phosphate-buffered saline (Wel-
gene, South Korea, LB001-02) and incubated in glucose-free DMEM (Welgene, South Korea, LM001-56) or RPMI1640 (Welgene,
South Korea, LM011-60) supplemented with dialyzed fetal bovine serum (TCB, 101DI) for indicated hours.
Generation of ULK1/ cells using CRISPR/Cas9
To generate KO cells, cells were transfected with px330 plasmids having following sequence: ULK1 Fw-50-AGCAGATCGCGGGCGC
CATG-30, Rv-50-CATGGCGCCCGCGATCTGCT-30. After transfection, single cells were grown until colonies form. KO cells were
selected based on protein expression and genomic DNA sequencing.
LC-ETD-MS/MS analysis
Flag-tagged ULK1 was coexpressed with OGT to induce O-GlcNAcylation. ULK1 was immunopurified using M2 beads, washed and
eluted. The protein was denatured with 8M urea in 50 mM ammonium bicarbonate (ABC) and followed by reduction and alkylation of
cysteine thiols. After dilution to 1Murea concentration with 50mMABCbuffer, protein digestion by trypsin was performed at 37C for
overnight. SPE clean up and sample concentration in speed-vac was preceded before mass spec analysis. LC-ETD-MS/MS exper-
iment was performed on Orbitrap Fusion Lumos mass spectrometry (Thermo Fisher Scientific) coupled with nanoACQUITY UPLC
(Waters) equipped with an in-house packed capillary analytical column (75 mm x 100 cm) and trap column (150 mm x 3 cm) with
3 mm Jupiter C18 particles (Phenomenex). The acquired ETD-MS/MS dataset was searched by MS-GF+ algorithm at 10 ppm of
precursor ion mass tolerance against the SwissProt Homo sapiens proteome database.
Plasmids
Px330 sgRNA cloning vector for generating CRISPR Cas9 KO for ULK1was acquired from Addgene (#42230). Sequence for siULK1
has been described previously (Gao et al., 2011). Mutations were introduced using nPfu-Forte mutagenesis kit (Enzynomics, P410).
Antibodies and reagents
Anti-Beclin1 antibody (NB110-87318) and anti-LC3B antibody (NB100-2220) were purchased from Novus Biologicals. Anti-ULK1 anti-
body (A7481), anti-Flag antibody (F3165), anti-ATG13 antibody (SAB4200100), anti-p-serine antibody (P5747), anti-b-actin antibody
(A1978) were from Sigma Aldrich; anti-PP1 antibody (sc-7482), anti-mTOR antibody (sc-1549-R) were from Santa Cruz Biotechnology;
anti-ATG14L antibody (Ab173943), anti-ATG101 antibody (Ab105387), anti-O-linked N-acetylglucosamine RLII antibody (Ab2739), and
anti-OGT antibody (Ab96718) were from Abcam; anti-p-S757 ULK1 antibody (#6888), anti-p-S555 ULK1 antibody (#5869), anti-p-T172
AMPK antibody (#2531), anti-p-S2448 mTOR antibody (#2971S) and anti-VPS34 antibody (#3811S) were from Cell Signaling; anti-HA
antibody (#MMS-101R) was fromCovance; anti-PP5 antibody (A300-909A) was fromBethyl Laboratories; L-a-Phosphatidylinositol so-
dium salt (P0639) was from Sigma Aldrich; WGA beads (AL-1023S) were from Vector Laboratories; Torin 1 (4247) and tautomycetin
(2305) were from Tocris. Transfection was performed with Lipofectamine 3000 (Invitrogen) according to the manufacturer’s protocol.
Co-immunoprecipitation assays
All cells were briefly rinsed with ice-cold PBS before collection. Cells were lysed in EBC200 buffer (50 mM Tris-HCl [pH 8.0], 0.2 M
NaCl, 0.5% NP-40, and protease inhibitors) on ice for 30 min. The lysates were collected and cleared by centrifugation at 14,0003 gCell Reports 25, 2878–2890.e1–e4, December 4, 2018 e3
for 10 min at 4C. Total protein concentration in the lysates was determined using the Bio-Rad Protein Assay Dye Reagent Concen-
trate (Bio-Rad, #500-0006). For co-immunoprecipitation assays, lysates were immunoprecipitated with protein A- and protein
G-Sepharose beads (GE Healthcare) for 2-4 hours with indicated antibodies. The beads were pelleted and washed five times
in EBC200 buffer and then resuspended in SDS-PAGE-loading buffer. Bound proteins were eluted by boiling, resolved by SDS-
PAGE, followed by immunoblot analysis. The blots were blocked and incubated in PBS containing 3% BSA and indicated antibody
for 2-4 hours. After six 10-min washes in 0.1% Triton X-100 in PBS (PBS-T), the blots were incubated in horse radish peroxidase-
conjugated secondary antibody in PBS-T/ 3% BSA for 1-2 hours. For detection of bound proteins, the blots were washed five times
in PBS-T, and then incubated in ECL.
Immunofluorescence microscopy
Cells grown on coverslips at a density of 73 104 cells were washed three times with PBS and then fixed with 2% paraformaldehyde in
PBS for 10 min at room temperature. Fixed cells were permeabilized with PBS-T for 10 min at room temperature. Blocking was per-
formed with 3% bovine serum in PBS-T for 30 min. For staining, cells were incubated with indicated antibodies for 4 hours at room
temperature, followed by incubation with fluorescent labeled secondary antibodies for 1 hour. The following fluorescent secondary
antibodies were used: donkey anti-mouse IgG; AlexaFluor 488, AlexaFluor 594; donkey anti-rabbit IgG AlexaFluor 488, AlexaFluor
594 (all from Invitrogen). Cells weremounted and visualized under a confocalmicroscope (Zeiss, LSM700). For autophagy studies, cells
were transfected with GFP-LC3/mCherry-GFP-LC3 and sub-cultured onto coverslips followed by glucose starvation and fixation. For
co-localization studies, cells were transfected with HA-PP1/Flag-ULK1 and sub-cultured onto coverslips followed by glucose starva-
tion and fixation. The following day, cells were incubated with either complete media or glucose starvation media for indicated times.
In vitro kinase assay
ULK1 proteins were immunoprecipitated from HEK293 cell with anti-Flag M2 agarose affinity gel (Sigma). The immune-complex was
extensively washed with BC150 (20 mM Tris-HCL, pH 7.9, 15% glycerol, 1 mM EDTA, 1mM DTT (dithiothreitol), 0.05% NP40, and
150 mMKCl for three times, and with BC300 (same as BC150 except for 300 mMKCl) for three times, and lastly with BC150 for three
times. Flag-peptide was used for elution from the affinity gel. His-ATG14L proteins were purified from E. coli strain M15pRep using
Ni-NTA resin (QIAGEN). ULK1 and ATG14L proteins were incubated in kinase assay buffer containing 10 mM HEPES at pH 7.4,
50 mM NaCl, 10 mM MgCl2, 10 mM MnCl2, 1 mM DTT, protease inhibitors. 10 mM cold ATG and 10 mCi [g-
32P]ATP were added
per reaction. The kinase reaction was performed at 37C for 30 min and the reaction was terminated by adding SDS sample buffer
and subjected to SDS–PAGE (polyacrylamide gel electrophoresis) and autoradiography.
In vitro VPS34 lipid kinase assay
Flag-tagged VPS34-expressing HEK293 cells were immunoprecipitated with anti-Flag M2-agarose affinity gel as immunoprecipita-
tion assay and washed with NP-40 buffer, eluted with 3X Flag peptide in TBS buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.4]).
Immuno-purified complexes were equilibrated in kinase base buffer (20 mM HEPES [pH 7.4], 1 mM EGTA, 0.4 mM EDTA, and
5 mM MgCl2) and then preincubated for 10 min at room temperature with 10 mM MnCl2 and 2 mg sonicated phosphatidylinositol
(Sigma). 10 mCi [g-32P] ATP and 1 mM cold ATP were added and incubated for 15 min at room temperature. The kinase reactions
were stopped by directly adding 10 mL 1 M HCl, followed by lipid extraction with 2 volumes of methanol/CHCl3 (1: 1). Samples
were vortexed and centrifuged at maximum speed for 10 min. The organic phase was loaded on a thin-layer chromatography plate
(Analtech). Resolution of phospho-lipid was achieved using a buffer composition of CHCl3/methanol/NH4OH (30%)/ water (129: 100:
4.29: 24). Resolved plates were analyzed by autoradiography.
In vitro OGT assay
Recombinant Flag-OGT protein purified from HEK293 cells and recombinant 6X His-tagged ULK1 protein purified from E. coli were
mixed in the reaction buffer (50 mM Tris-HCl pH 7.5, 12.5 mM MgCl2, 2 mM UDP-GlcNAc, 1 mM DTT) in a final volume of 25 ml per
sample. The samples were incubated at 37C for 24 hours. The reaction was resolved with SDS-PAGE, blotted onto a polyvinylidene
difluoride (PVDF) membrane, followed by immunoblotting with anti-O-GlcNAc antibody to detect O-GlcNAcylation of ULK1.
QUANTIFICATION AND STATISTICAL ANALYSIS
All experiments were performed independently at least three times. Values are expressed as mean ± s.e.m. Significance was
analyzed by one-tailed, unpaired t test or one-way ANOVA using GraphPad Prism software. p < 0.05 was considered statistically
significant. *p < 0.01, **p < 0.001, ***p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
Raw data have been deposited to Mendeley Data and are available at https://data.mendeley.com/datasets/259594j572/1.e4 Cell Reports 25, 2878–2890.e1–e4, December 4, 2018
